The Trifunctional Antibody Ertumaxomab Destroys Tumor Cells That Express Low Levels of Human Epidermal Growth Factor Receptor 2
Cancer Research - United States
doi 10.1158/0008-5472.can-08-2861
Full Text
Open PDFAbstract
Available in full text
Date
May 12, 2009
Authors
Publisher
American Association for Cancer Research (AACR)